Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · IEX Real-Time Price · USD
3.040
-0.040 (-1.30%)
Mar 28, 2024, 4:30 PM EDT - Market closed

Aytu BioPharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014
Revenue
107.496.6765.6327.637.323.663.222.560.260.06
Revenue Growth (YoY)
11.10%47.29%137.52%277.47%100.00%13.61%25.72%878.85%344.23%-
Cost of Revenue
40.7744.3936.438.282.22.051.420.960.090
Gross Profit
66.6352.2829.219.355.121.611.81.610.170.06
Selling, General & Admin
70.0869.8855.8131.0619.2417.7317.618.834.292.35
Research & Development
4.112.665.621.720.590.171.356.323.424.06
Other Operating Expenses
10.4981.326.647.72.143.412.978.160.090
Operating Expenses
84.67163.8488.0740.4821.9621.3121.9323.317.816.41
Operating Income
-18.03-111.56-58.87-21.13-16.85-19.7-20.13-21.7-7.63-6.35
Interest Expense / Income
0000002.535.490.110.05
Other Expense / Income
-0.98-2.67-0.84-7.5110.29-9.51-0.150.98--
Pretax Income
-17.05-108.89-58.03-13.62-27.13-10.19-22.51-28.18-7.75-6.39
Income Tax
0-0.110.2600000-0.02-0.81
Net Income
-17.05-108.78-58.29-13.62-27.13-10.19-22.51-28.18-7.72-5.58
Shares Outstanding (Basic)
3110000000
Shares Outstanding (Diluted)
3110000000
Shares Change
127.22%75.54%270.57%479.80%1071.03%42.83%10490.91%120.00%42.86%-
EPS (Basic)
-5.11-74.01-69.60-60.20-696.00-3062.00-9660.00-1294800.00-805600.00-768000.00
EPS (Diluted)
-5.11-74.01-69.60-60.20-696.00-3062.00-9660.00-1294800.00-805600.00-768000.00
Free Cash Flow
-5.13-28.82-25.96-28.37-13.89-16.02-13.94-10.91-6.63-5.51
Free Cash Flow Per Share
-1.54-19.61-31.01-125.57-356.44-4812.17-5983.06-501304.03-691640.32-761328.91
Gross Margin
62.04%54.08%44.49%70.03%69.92%43.98%56.00%62.65%66.34%100.00%
Operating Margin
-16.79%-115.41%-89.70%-76.47%-230.13%-538.24%-624.70%-847.02%-2915.53%-10770.31%
Profit Margin
-15.88%-112.53%-88.81%-49.29%-370.64%-278.35%-698.67%-1099.73%-2950.32%-9466.80%
Free Cash Flow Margin
-4.78%-29.82%-39.56%-102.69%-189.76%-437.55%-432.74%-425.78%-2534.25%-9352.37%
EBITDA
-8.24-98.74-48.83-7.91-24.4-7.6-15.61-21.81-7.51-6.25
EBITDA Margin
-7.67%-102.15%-74.40%-28.62%-333.38%-207.55%-484.52%-851.29%-2870.37%-10604.89%
Depreciation & Amortization
8.8210.159.25.712.732.594.360.870.120.1
EBIT
-17.05-108.89-58.03-13.62-27.13-10.19-19.97-22.69-7.63-6.35
EBIT Margin
-15.88%-112.64%-88.42%-49.29%-370.64%-278.35%-620.00%-885.43%-2915.53%-10770.31%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).